Diagnosing Sjögren–Larsson syndrome in a 7‐year‐old Moroccan boy
- 1 March 2007
- journal article
- case report
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 34 (3) , 270-275
- https://doi.org/10.1111/j.1600-0560.2006.00603.x
Abstract
Sjögren-Larsson syndrome (SLS) is an autosomal recessively inherited neurocutaneous disorder characterized by the triad of congenital ichthyosis, mental deficiency, and spastic diplegia or tetraplegia. Less common features are retinal changes, short stature, kyphoscoliosis, preterm birth, photophobia, reduction of visual acuity, seizures, and delayed speech. SLS is characterized by a genetic block in the oxidation of fatty alcohol to fatty acid because of deficient activity of fatty aldehyde dehydrogenase (FALDH), a component of the fatty alcohol: NAD oxidoreductase enzyme complex. As in other rare multisystem diseases, the diagnosis of SLS is often delayed. The definitive test for SLS is considered the measurement of FALDH or fatty alcohol: NAD oxidoreductase in cultured skin fibroblasts. Nevertheless, if specific FALDH activity test or DNA FALDH gene mutation tests are not available (as in our country), a reliable diagnosis of SLS is also possible when it is based on the matching of peculiar clinical, histologic and ultrastructural, laboratoristic, and imaging features. The simultaneous presence of cutaneous histologic features including hyperkeratosis, orthokeratosis, thickening of granular layer, abnormal lamellar inclusions in the cytoplasm of granular and horny cells (demonstrated by light and electron microscopy) in a child with ichthyosis, and typical neurologic abnormalities is highly suggestive of SLS. We describe the case of a young Moroccan boy presenting with ichthyosis, mental retardation, spastic diplegia, and peculiar skin histologic findings.Keywords
This publication has 17 references indexed in Scilit:
- Sjögren–larsson syndrome: treatment with topical calcipotriolPediatric Dermatology, 2003
- Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren–Larsson syndromeChemico-Biological Interactions, 2001
- 5-Lipoxygenase Inhibition: A New Treatment Strategy for Sjögren-Larsson SyndromeNeuropediatrics, 2000
- Defective inactivation of leukotriene B4 in patients with Sjo ̈gren-Larsson syndromeThe Journal of Pediatrics, 2000
- Sjögren–Larsson syndromeNeurology, 1999
- An appraisal of acitretin therapy in children with inherited disorders of keratinizationBritish Journal of Dermatology, 1996
- Inherited Ichthyoses: A Review of the Histology of the SkinFetal and Pediatric Pathology, 1996
- Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.Journal of Clinical Investigation, 1991
- Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.Journal of Clinical Investigation, 1988
- Studies of the skin in Sjögren-Larsson syndrome by electron microscopyThe American Journal of Dermatopathology, 1982